Markets
Long
@long_gam...
Bought SANA
Shares
down -3.37%
At 2.67, Exited 2.58
I believe SANA is about to see a strong rebound after presenting their 8-week interim analysis on Monday. Given the positive results so far, I expect ...
Read
More
Thesis
I believe SANA is about to see a strong rebound after presenting their 8-week interim analysis on Monday. Given the positive results so far, I expect the stock to spike again like it did previously, especially with their potential to revolutionize diabetes treatment on the horizon.
Go back
Degenerate
@wsb
Bought SANA
Calls
down -33.33%
At 0.15, Exited 0.1
Contract:
5 Strike Call for
Feb 21
I believe $SANA is fundamentally undervalued considering its revolutionary immune-evasive tech. With potential catalysts on the horizon and a market c...
Read
More
Thesis
I believe $SANA is fundamentally undervalued considering its revolutionary immune-evasive tech. With potential catalysts on the horizon and a market cap that's a fraction of the market potential, I see a solid opportunity here. I'm loading up on OTM calls to capitalize on any upswing, targeting $10 soon.
Go back
Tendies
@tendies
Bought SANA
Shares
up 7.38%
At 3.25, Exited 3.49
I'm loading up on SANA shares because I believe the advancements in their Hypo immune technology could revolutionize the treatment of diseases like ty...
Read
More
Thesis
I'm loading up on SANA shares because I believe the advancements in their Hypo immune technology could revolutionize the treatment of diseases like type 1 diabetes. With promising early trial results and the CEO's strong track record, I see significant upside potential as market awareness increases.
Go back
Scalp
@scalpgan...
Bought SANA
Puts
up 8.7%
At 1.15, Exited 1.25
Contract:
5 Strike Put for
Jan 17
After observing SANA's significant parabolic move up over 220%, I believe there's a critical opportunity to capitalize on its decline by taking out pu...
Read
More
Thesis
After observing SANA's significant parabolic move up over 220%, I believe there's a critical opportunity to capitalize on its decline by taking out puts. Given the volatility, it's a perfect play to ride the downward correction.
Go back
Scalp
@scalpgan...
Bought SANA
Shares
down -33.82%
At 5.53, Exited 3.66
I just saw the fantastic news about SANA and their groundbreaking results in treating Type 1 Diabetes. With the positive clinical results and the high...
Read
More
Thesis
I just saw the fantastic news about SANA and their groundbreaking results in treating Type 1 Diabetes. With the positive clinical results and the high pre-market volume, I think there’s a good chance for a breakout today, and I’m looking to capitalize on that.
Go back
Tendies
@tendies
Bought SANA
Shares
down -38.92%
At 7.04, Exited 4.3
I'm all in on SANA after their promising clinical results for type 1 diabetes. The potential upside is massive, especially with the company's strong c...
Read
More
Thesis
I'm all in on SANA after their promising clinical results for type 1 diabetes. The potential upside is massive, especially with the company's strong cash position and the recent price movement. I believe we could see this stock push over $10 very soon and it’s definitely undervalued right now.
Go back
Duquesne
@duquesne...
Bought SANA
Shares
down -46.05%
At 10.12, Exited 5.46
Thesis
Go back
